Related Experiment Video
Updated: Feb 11, 2026

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
Influence of sphingosine-1-phosphate signaling on HCMV replication in human embryonal lung fibroblasts
Anika Zilch1, Christian Rien1, Cynthia Weigel2,3
1Section Experimental Virology, Institute of Medical Microbiology, University Hospital Jena, Friedrich Schiller University Jena, Hans-Knöll-Str. 2, 07745, Jena, Germany.
Abstract:
The human cytomegalovirus (HCMV) is a common pathogen, which causes severe or even deadly diseases in immunocompromised patients. In addition, congenital HCMV infection represents a major health concern affecting especially the lung tissue of the susceptible individuals. Antivirals are a useful strategy to treat HCMV-caused diseases. However, all approved drugs target viral proteins but significant toxicity and an increasing resistance against these compounds have been observed. In infected cells, numerous host molecules have been identified to play important roles during HCMV replication. Among others, HCMV infection depends on the presence of bioactive sphingolipids. In this study, the role of sphingosine-1-phosphate (S1P) signaling in HCMV-infected human embryonal lung fibroblasts (HELF) was analyzed. Viral replication depended on the functional activity of sphingosine kinases (SK). During SK inhibition, addition of extracellular S1P restored HCMV replication. Moreover, neutralization of extracellular S1P by anti-S1P antibodies decreased HCMV replication as well. While the application of FTY720 as an functional antagonist of S1P receptor (S1PR)1,3-5 signaling did not reduce HCMV replication significantly, JTE-013, an inhibitor of S1PR2, decreased viral replication. Furthermore, inhibition of Rac-1 activity reduced HCMV replication, whereas inhibition of the Rac-1 effector protein Rac-1-activated kinase 1 (PAK1) had no influence. In general, targeting S1P-induced pathways, which are essential for a successful HCMV replication, may represent a valuable strategy to develop new antiviral drugs.
Insights
Human cytomegalovirus (HCMV) replication relies on sphingosine-1-phosphate (S1P) signaling pathways. Targeting these host cell pathways, particularly S1PR2, offers a promising strategy for novel antiviral drug development against HCMV.
Area of Science:
- Virology
- Cell Biology
- Immunology
Background:
- Human cytomegalovirus (HCMV) causes severe disease in immunocompromised individuals and congenital infections.
- Current antiviral drugs targeting viral proteins have limitations including toxicity and resistance.
- Host cell molecules, particularly bioactive sphingolipids, are crucial for HCMV replication.
Purpose of the Study:
- To investigate the role of sphingosine-1-phosphate (S1P) signaling in HCMV replication within human embryonal lung fibroblasts (HELF).
- To identify specific sphingolipid pathways and receptors involved in supporting viral replication.
- To explore the potential of targeting S1P signaling as a novel antiviral strategy.
Main Methods:
- Analysis of HCMV replication in HELF cells under conditions of sphingosine kinase (SK) inhibition and S1P modulation.
- Application of extracellular S1P, anti-S1P antibodies, and specific sphingosine-1-phosphate receptor (S1PR) antagonists (FTY720, JTE-013).
- Investigation of the role of Rac-1 signaling pathway components (Rac-1, PAK1) in HCMV replication.
Main Results:
- HCMV replication was dependent on the functional activity of sphingosine kinases (SK).
- Restoration of viral replication was observed upon addition of extracellular S1P during SK inhibition.
- Neutralization of extracellular S1P and inhibition of S1PR2 significantly decreased HCMV replication.
- Inhibition of Rac-1 activity reduced viral replication, while PAK1 inhibition had no effect.
Conclusions:
- Sphingosine-1-phosphate (S1P) signaling is essential for efficient human cytomegalovirus (HCMV) replication.
- S1PR2 and Rac-1 pathways are critical host factors supporting HCMV infection.
- Targeting S1P-induced pathways presents a viable strategy for developing new antiviral therapies against HCMV.
Related Concept Videos
DNA Replication
Replication in Prokaryotes
DNA replication...
Chromosome Replication
Replication in Eukaryotes
Restarting Stalled Replication Forks
Interpreting ¹H NMR Signal Splitting: The (n + 1) Rule
Replication in Prokaryotes

